Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Tresiba for the treatment of diabetes mellitus in adults after review of the class II resubmissions of the New Drug Application (NDA). Via Drugs.com. Posted September 25, 2015.
–Alanna McCatty
